Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in metastatic soft tissue sarcoma.
Robin Jones,BSc, MB, MRCP, MD
Articles by Robin Jones,BSc, MB, MRCP, MD
Latest Updated Articles
Dr. Robin Jones on Olaratumab and Doxorubicin Combination in Patients with Soft Tissue SarcomaPublished: December 4th 2015 | Updated: